Abstract
We highlight the feasibility and efficacy of a new application for catheter ablation to target atrial ganglionated plexi in a patient with refractory vasovagal syncope. We describe a physiologically guided technique and demonstrate 18-month freedom from syncope with 2 tilt-table tests to objectively assess reproducible elimination of symptomatology and underlying pathophysiology. (Level of Difficulty: Beginner.).